"None of this is normal. Nobody should go through this," Heather Barry, a mom of three, said in a recent interview ...

Primary neuroendocrine carcinoma of the male breast is an exceptionally rare entity, with fewer than 50 cases documented in ...

A new study from Cornell University has strengthened the case for using a specific group of molecules—known as microRNAs—as ...

Heather Barry was diagnosed with rectal cancer after giving birth. Her symptoms appeared months after pregnancy, including ...

Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United ...

Helene Lindfors, Ph.D. Student at the Endocrine Surgery research group, the Department of Molecular Medicine and Surgery, ...

A phase 2 trial will evaluate leronlimab’s safety and efficacy for the treatment of patients with microsatellite stable ...

A team of Singapore scientists has made a significant discovery in understanding stomach cancer, a disease that remains one ...

BDC-3042 is a proprietary agonist antibody that targets dectin-2, an immune-activating receptor expressed by tumor-associated macrophages (TAMs). This single-agent, dose-escalation Phase 1 clinical ...

Black Americans face higher rates and lower survival. Research explores biological, social factors, and disparities.

What drew you to pursue a career in oncology and what is it that inspires you most about working in this field?